Table 2.

Clinical and pathological features of the patients who experienced recurrence

Pt #	Age	Sex	MG	NLR	NT	WHO	Masaoka	TNM	AT	DFS	Site	OS	LFU
14	36	M	yes	2.16	no	B3	III	IIIA	yes	27	LR	31	AL
15	63	M	no	5.85	no	B3	III	IIIB	yes	16	LR	47	AL
32	50	M	no	1.68	yes	B2	IV	IIIA	yes	48	LR	61	AL
39	36	M	no	2.27	no	B2	III	I	yes	48	LR	99	AL
50	72	M	no	2.46	no	B3	II	I	yes	24	LR	75	D
66	52	F	no	2.61	yes	B2	III	IIIA	yes	57	LR	59	AL

Legend: NT Neoadjuvant therapy, AT Adjuvant therapy, LR Loco-regional recurrence, LFU Status at the time of the last follow up, AL Alive, D Deceased